71825-51-9 Usage
General Description
2-methyl-2-(4-nitrophenyl)propanenitrile, also known as 4-nitrophenylpropiophenone, is a chemical compound with the molecular formula C10H10N2O2. It is a yellow solid that is commonly used as an intermediate in the synthesis of pharmaceuticals and organic compounds. The compound is notable for its nitrile and nitro functional groups, which make it a versatile building block for various chemical reactions and molecular modifications. 2-methyl-2-(4-nitrophenyl)propanenitrile has applications in the production of dyes, pigments, and other organic chemicals, and it is important to handle it with care due to its potential toxicity and environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 71825-51-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,8,2 and 5 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 71825-51:
(7*7)+(6*1)+(5*8)+(4*2)+(3*5)+(2*5)+(1*1)=129
129 % 10 = 9
So 71825-51-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2O2/c1-10(2,7-11)8-3-5-9(6-4-8)12(13)14/h3-6H,1-2H3
71825-51-9Relevant articles and documents
Cobalt-catalyzed C[sbnd]H activation/C[sbnd]O formation: Synthesis of benzofuranones
Hajipour, Abdol R.,Khorsandi, Zahra
, (2019/11/26)
Herein, C[sbnd]H activation/C[sbnd]O formation reaction using novel cobalt catalytic system is reported. This reaction was given benzofuranones in moderate to excellent yields at room-temperature under air reaction conditions. The introduced strategy is efficient and low-cost method to synthesized benzofuranones from α,α-disubstitution acetic acid.
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
-
Paragraph 00439, (2017/10/06)
The present invention provides compounds, compositions thereof, and methods of using the same.
Imidazole derivatives, its pharmaceutical composition and use thereof
-
Paragraph 0199-0200, (2017/02/24)
Imidazolone compounds, pharmaceutically acceptable salts, solvates, polymorphs or prodrugs thereof are disclosed. Pharmaceutical compositions comprising above substances and uses for preventing and treating protein kinases related diseases, such as cancers, metabolic diseases, cardiovascular diseases and the like, are also disclosed.